|Bid||20.65 x 800|
|Ask||20.72 x 1300|
|Day's range||19.95 - 20.78|
|52-week range||1.92 - 33.79|
|Beta (5Y monthly)||1.31|
|PE ratio (TTM)||N/A|
|Earnings date||10 Aug 2020|
|Forward dividend & yield||N/A (N/A)|
|1y target est||22.33|
Robinhood investors like two fast-growing biotechs and one big pharma company that each have promising COVID-19 vaccine candidates.
Inovio Pharmaceuticals (NASDAQ: INO) is enjoying its best stock performance in seven years thanks to investors' interest in its novel coronavirus vaccine program. VBI Vaccines (NASDAQ: VBIV) appears to be on track for its best year ever -- for the same reason. There are currently 25 COVID-19 vaccine candidates in clinical testing across the world.
There are no signs the coronavirus pandemic is slowing down in the U.S., with more than 1,100 Americans dying every day from COVID-19 in recent days. Beyond the staggering fatalities, one estimate by the Australian National University puts the virus' potential global economic damage at over $21 trillion. The need for a coronavirus vaccine has thus become paramount to saving lives and mitigating economic catastrophes.